Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Keefe

Showing results (141-150 of 255) with videos related to

Pageof 26
Sort By:
Schizophrenia Research|September 15, 2020
Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measuresPhilip D Harvey, William P Horan, Alexandra S Atkins, et al.
Molecular Psychiatry|June 17, 2015
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trialsY Iwata, S Nakajima, T Suzuki, et al.
Journal of the International Neuropsychological Society : JINS|February 20, 2008
Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophreniaS Kristian Hill, John A Sweeney, Robert M Hamer, et al.
Schizophrenia Bulletin|March 3, 2010
Report from the working group conference on multisite trial design for cognitive remediation in schizophreniaRichard S E Keefe, Sophia Vinogradov, Alice Medalia, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 13, 2007
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trialRichard S E Keefe, Anil K Malhotra, Herbert Y Meltzer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Persistent cannabis users show neuropsychological decline from childhood to midlifeMadeline H Meier, Avshalom Caspi, Antony Ambler, et al.
Psychological Medicine|June 3, 2006
Insight in first-episode psychosisJoseph P McEvoy, Jackie Johnson, Diana Perkins, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 17, 2014
Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating ScaleRichard S E Keefe, Vicki G Davis, Nathan B Spagnola, et al.
The Journal of Clinical Psychiatry|April 2, 2016
A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective DisorderJoshua T Kantrowitz, Zafar Sharif, Alice Medalia, et al.
Community Mental Health Journal|November 30, 2010
Criminal justice system involvement among people with schizophreniaGreg Greenberg, Robert A Rosenheck, Steven K Erickson, et al.
Pageof 26

Showing results (141-150 of 255) with videos related to

Sort By:
Pageof 26
Schizophrenia Research|September 15, 2020
Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measuresPhilip D Harvey, William P Horan, Alexandra S Atkins, et al.
Molecular Psychiatry|June 17, 2015
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trialsY Iwata, S Nakajima, T Suzuki, et al.
Journal of the International Neuropsychological Society : JINS|February 20, 2008
Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophreniaS Kristian Hill, John A Sweeney, Robert M Hamer, et al.
Schizophrenia Bulletin|March 3, 2010
Report from the working group conference on multisite trial design for cognitive remediation in schizophreniaRichard S E Keefe, Sophia Vinogradov, Alice Medalia, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 13, 2007
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trialRichard S E Keefe, Anil K Malhotra, Herbert Y Meltzer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Persistent cannabis users show neuropsychological decline from childhood to midlifeMadeline H Meier, Avshalom Caspi, Antony Ambler, et al.
Psychological Medicine|June 3, 2006
Insight in first-episode psychosisJoseph P McEvoy, Jackie Johnson, Diana Perkins, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 17, 2014
Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating ScaleRichard S E Keefe, Vicki G Davis, Nathan B Spagnola, et al.
The Journal of Clinical Psychiatry|April 2, 2016
A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective DisorderJoshua T Kantrowitz, Zafar Sharif, Alice Medalia, et al.
Community Mental Health Journal|November 30, 2010
Criminal justice system involvement among people with schizophreniaGreg Greenberg, Robert A Rosenheck, Steven K Erickson, et al.
Pageof 26